குவிமிகா News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from குவிமிகா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In குவிமிகா Today - Breaking & Trending Today
La última novedad de Google es una tabla periódica interactiva. Incluye todos los datos posibles, así como una representación en 3D. ....
Chart: Vaccine Coverage and Supply Deals Getting a population vaccinated means first securing the doses. AS/COA Online looks at vaccine population coverage, supply agreements, and regulatory approvals in the region.
April 4, 2021 El Salvador’s President Nayib Bukele announces the country will receive 150,000 additional doses donated by China. This comes one week after the country received 1 million Sinovac doses, which will be administered on priority groups such as healthcare workers, educators, police, and military personnel. Given that the vaccine requires one shot, the delivery is enough to cover 15 percent of the country’s population. President Bukele tweeted that these shots are part of a 2-million-dose deal with the Chinese manufacturer. El Salvador switched diplomatic recognition from Taipei to Beijing in 2018. ....
Timeline: Latin America's Road to Get Vaccinated as-coa.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from as-coa.org Daily Mail and Mail on Sunday newspapers.
Brazilian firm plans to export Russian COVID vaccine to South America 19 Jan 2021 - 23:35 FILE PHOTO: Bottles of Russia s Sputnik-V COVID-19 vaccine are seen before inoculation at a clinic in Tver, Russia, October 12, 2020. REUTERS/Tatyana Makeyeva/File Photo Reuters BRASILIA - Brazilian pharmaceutical company União Quimica plans to press ahead with production of Russia s Sputnik V vaccine with a view to exporting it to other parts of South America. It and Russian sovereign wealth fund RDIF, which is marketing Sputnik V for Russia s Gamaleya Institute, last week filed for emergency use approval from Brazilian health regulator Anvisa, but were told more documentation was needed. ....